Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.40) by 2.5 percent. This is a 16.33 percent increase over losses of $(0.49) per share from the same period last year.
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.40) by 2.5 percent. This is a 16.33 percent increase over losses of $(0.49) per share from the same period last year.
Comments